© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Cefodizime Sodium stands out as a third-generation cephalosporin antibiotic, widely recognized for its ability to treat a variety of bacterial infections. Pharmaceutical manufacturers rely on this compound due to its enhanced resistance to bacterial enzymatic degradation, offering stable and predictable outcomes during formulation and administration. As an odorless, off-white to light yellow solid, Cefodizime Sodium comes in different forms such as powder, flakes, or crystalline material, enabling use in both small-scale labs and mass production settings. The compound dissolves readily in water, producing clear to slightly opalescent solutions that help with intravenous or intramuscular delivery routes. From a hands-on perspective, its crystalline nature often signals a higher degree of purity, a feature many laboratory technicians prioritize when selecting raw materials for formulation.
An understanding of the compound’s structure goes beyond textbook curiosity. Cefodizime Sodium features a beta-lactam ring fused to a dihydrothiazine, alongside a unique aminothiazole moiety, conferring both antibacterial potency and improved pharmacokinetics. The molecular formula is C20H18N7NaO7S3 with a molecular weight around 589.6 g/mol, an essential parameter for anyone tasked with compounding precise dosages. Each change in the crystalline structure—such as the difference between powder and pearl forms—can impact solubility and rate of reconstitution, knowledge that saves valuable time in busy clinical settings. This level of detail around stereochemistry and substituent groups means professionals can anticipate interactions or stability concerns with excipients, helping keep both efficacy and safety top-of-mind.
Cefodizime Sodium showcases several physical characteristics worth knowing. Typically, this compound appears as a solid in the form of flakes, powder, or fine crystals. On occasion, material may take on a more granular pearl-like quality. The bulk density usually falls within 0.25–0.35 g/cm³, influencing storage and transport decisions for both buyers and distributers. In the lab, direct contact yields little dust and minimal odor, improving handling compared to other cephalosporins. Aqueous solutions turn a clear, pale yellow at standard concentrations, a visual check that technicians use to confirm both purity and correct dilution. Pharmacists must pay close attention to hygroscopicity; exposure to moisture leads to clumping, so storage in airtight containers under dry conditions is essential.
Batch release depends on strict adherence to specifications. Most pharmaceutical producers confirm identity using high-performance liquid chromatography, infrared spectroscopy, or titration, all with documented reference standards. Typical assays aim for 98–102% purity, with limits on heavy metals and residual solvents. The product’s specific rotation sits between ranges established in pharmacopeias, serving as an indicator of stereoisomeric purity. Endotoxin and bioburden counts must meet tight regulatory guidelines, especially for materials intended for injection. In real-world manufacturing, a single out-of-specification batch means delays, costly recalls, and medication shortages—so everyone from plant operator to quality control chemist takes these numbers seriously.
For global trade, Cefodizime Sodium usually carries the Harmonized System (HS) Code 29419090, falling within the category of other antibiotics. Accurate use of this code allows importers and exporters to declare cargo at customs without unnecessary confusion or delay. Regulatory agencies like the European Medicines Agency, U.S. FDA, and China’s NMPA each outline purity, safety, and labeling protocols for Cefodizime Sodium. Incorrect documentation at this step can create barriers to launch, harming both consumer access and company bottom lines.
Cefodizime Sodium, like any potent antibiotic, presents several safety considerations for workers and end users. Individuals may experience skin or respiratory irritation when handling powders, so personal protective equipment—including gloves and masks—should always be standard practice. Accidental inhalation or direct skin contact might cause allergic reactions in sensitive individuals, making well-ventilated storage and clear labeling non-negotiable. From a chemical hazards viewpoint, its sodium salt structure means it dissolves rapidly in water, with the resulting solutions generally stable at neutral to slightly alkaline pH. Disposal must comply with chemical waste guidelines to avoid environmental contamination—antibiotics in water systems contribute to resistance, threatening public health far beyond a single facility.
Cefodizime Sodium acts as a raw material for developing injectables and other dosage forms aimed at fighting bacterial infections resistant to older cephalosporins. Formulators look at attributes such as particle size, density, and solubility before integrating it into production lines. Hospital pharmacists count on batch-to-batch consistency to ensure patient safety and treatment success. In real-world healthcare, stock-outs or substandard lots directly affect patient outcomes; the need for reliable supply chains and vigilant monitoring becomes clear. The growing threat of antimicrobial resistance puts pressure on the industry to maintain strict stewardship of antibiotics like Cefodizime Sodium, ensuring they remain effective tools in medical treatment.
